(Q37122668)

English

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study

scientific article published on 19 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study (English)

1 reference

Europe PubMed Central

18 August 2017

multicenter clinical trial

0 references

budesonide/formoterol

1 reference

based on heuristic

inferred from title

Claus Vogelmeier

3

object named as

Claus Vogelmeier

1 reference

Europe PubMed Central

18 August 2017

author name string

Björn Ställberg

1

1 reference

Europe PubMed Central

18 August 2017

Olof Selroos

2

1 reference

Europe PubMed Central

18 August 2017

Eva Andersson

4

1 reference

Europe PubMed Central

18 August 2017

Tommy Ekström

5

1 reference

Europe PubMed Central

18 August 2017

Kjell Larsson

6

1 reference

Europe PubMed Central

18 August 2017

publication date

19 February 2009

1 reference

Europe PubMed Central

18 August 2017

Respiratory Research

1 reference

Europe PubMed Central

18 August 2017

10

1 reference

Europe PubMed Central

18 August 2017

11

1 reference

Europe PubMed Central

18 August 2017

https://scigraph.springernature.com/pub.10.1186/1465-9921-10-11

0 references

Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

The role of systemic corticosteroids in acute exacerbation of chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Development, validity and responsiveness of the Clinical COPD Questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Toward a consensus definition for COPD exacerbations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Impact on patients' health status following early identification of a COPD exacerbation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

14 September 2017

Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

27 June 2018

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

27 June 2018

Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

The role of nebulised budesonide in the treatment of exacerbations of COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653467

3 September 2018

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term treatment with corticosteroids in COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of oral prednisone in outpatients with acute COPD exacerbation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein levels and clinically important predictive outcomes in stable COPD patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The systemic face of airway diseases: the role of C-reactive protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory changes, recovery and recurrence at COPD exacerbation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1465-9921-10-11

1 reference

Europe PubMed Central

18 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37122668&oldid=1688132028"